Cargando…
Compound heterozygous SLC19A3 mutations further refine the critical promoter region for biotin-thiamine-responsive basal ganglia disease
Mutations in the gene SLC19A3 result in thiamine metabolism dysfunction syndrome 2, also known as biotin-thiamine-responsive basal ganglia disease (BTBGD). This neurometabolic disease typically presents in early childhood with progressive neurodegeneration, including confusion, seizures, and dysphag...
Autores principales: | Whitford, Whitney, Hawkins, Isobel, Glamuzina, Emma, Wilson, Francessa, Marshall, Andrew, Ashton, Fern, Love, Donald R., Taylor, Juliet, Hill, Rosamund, Lehnert, Klaus, Snell, Russell G., Jacobsen, Jessie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701311/ https://www.ncbi.nlm.nih.gov/pubmed/28696212 http://dx.doi.org/10.1101/mcs.a001909 |
Ejemplares similares
-
Whole exome sequencing reveals compound heterozygous mutations in SLC19A3 causing biotin-thiamine responsive basal ganglia disease
por: Sremba, L.J., et al.
Publicado: (2014) -
Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy
por: Flønes, Irene, et al.
Publicado: (2016) -
Psychological Assessment of Patients With Biotin-Thiamine-Responsive Basal Ganglia Disease
por: Alfadhel, Majid, et al.
Publicado: (2017) -
Biotin-thiamine-responsive basal ganglia disease: A case report
por: Majumdar, Shamaita, et al.
Publicado: (2021) -
An unusually mild case of biotin-thiamine-responsive basal ganglia disease
por: Lail, Gurnoor, et al.
Publicado: (2023)